Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $4.79 Million - $5.46 Million
-30,000 Reduced 50.0%
30,000 $5.46 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $8.02 Million - $9.28 Million
60,000 New
60,000 $8.94 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Nicola Wealth Management Ltd. Portfolio

Follow Nicola Wealth Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicola Wealth Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Nicola Wealth Management Ltd. with notifications on news.